AAAAAA

   
Results: 1-17 |
Results: 17
FOLLOW-UP OF RELAPSED B-CELL LYMPHOMA PATIENTS TREATED WITH IODINE-131-LABELED ANTI-CD20 ANTIBODY AND AUTOLOGOUS STEM-CELL RESCUE
Authors: LIU SY EARY JF PETERSDORF SH MARTIN PJ MALONEY DG APPELBAUM FR MATTHEWS DC BUSH SA DURACK LD FISHER DR GOOLEY TA BERNSTEIN ID PRESS OW
Citation: Sy. Liu et al., FOLLOW-UP OF RELAPSED B-CELL LYMPHOMA PATIENTS TREATED WITH IODINE-131-LABELED ANTI-CD20 ANTIBODY AND AUTOLOGOUS STEM-CELL RESCUE, Journal of clinical oncology, 16(10), 1998, pp. 3270-3278
BONE-MARROW TRANSPLANTS FROM UNRELATED DONORS FOR PATIENTS WITH CHRONIC MYELOID-LEUKEMIA
Authors: HANSEN JA GOOLEY TA MARTIN PJ APPELBAUM F CHAUNCEY TR CLIFT RA PETERSDORF EW RADICH J SANDERS JE STORB RF SULLIVAN KM ANASETTI C
Citation: Ja. Hansen et al., BONE-MARROW TRANSPLANTS FROM UNRELATED DONORS FOR PATIENTS WITH CHRONIC MYELOID-LEUKEMIA, The New England journal of medicine, 338(14), 1998, pp. 962-968
EFFECT OF HIGH-DOSE ACYCLOVIR ON SURVIVAL IN ALLOGENEIC MARROW TRANSPLANT RECIPIENTS WHO RECEIVED GANCICLOVIR AT ENGRAFTMENT OR FOR CYTOMEGALOVIRUS PP65 ANTIGENEMIA
Authors: BOECKH M GOOLEY TA BOWDEN RA
Citation: M. Boeckh et al., EFFECT OF HIGH-DOSE ACYCLOVIR ON SURVIVAL IN ALLOGENEIC MARROW TRANSPLANT RECIPIENTS WHO RECEIVED GANCICLOVIR AT ENGRAFTMENT OR FOR CYTOMEGALOVIRUS PP65 ANTIGENEMIA, The Journal of infectious diseases, 178(4), 1998, pp. 1153-1157
OPTIMIZING OUTCOME AFTER UNRELATED MARROW TRANSPLANTATION BY COMPREHENSIVE MATCHING OF HLA CLASS-I AND CLASS-II ALLELES IN THE DONOR AND RECIPIENT
Authors: PETERSDORF EW GOOLEY TA ANASETTI C MARTIN PJ SMITH AG MICKELSON EM WOOLFREY AE HANSEN JA
Citation: Ew. Petersdorf et al., OPTIMIZING OUTCOME AFTER UNRELATED MARROW TRANSPLANTATION BY COMPREHENSIVE MATCHING OF HLA CLASS-I AND CLASS-II ALLELES IN THE DONOR AND RECIPIENT, Blood, 92(10), 1998, pp. 3515-3520
BONE-MARROW TRANSPLANTATION FOR CHILDREN LESS-THAN 2 YEARS OF AGE WITH ACUTE MYELOGENOUS LEUKEMIA OR MYELODYSPLASTIC SYNDROME
Authors: WOOLFREY AE GOOLEY TA SIEVERS EL MILNER LA ANDREWS RG WALTERS M HOFFMEISTER P HANSEN JA ANASETTI C BRYANT E APPELBAUM FR SANDERS JE
Citation: Ae. Woolfrey et al., BONE-MARROW TRANSPLANTATION FOR CHILDREN LESS-THAN 2 YEARS OF AGE WITH ACUTE MYELOGENOUS LEUKEMIA OR MYELODYSPLASTIC SYNDROME, Blood, 92(10), 1998, pp. 3546-3556
STEM-CELL TRANSPLANTATION FOR SECONDARY ACUTE MYELOID-LEUKEMIA - EVALUATION OF TRANSPLANTATION AS INITIAL THERAPY OR FOLLOWING INDUCTION CHEMOTHERAPY
Authors: ANDERSON JE GOOLEY TA SCHOCH G ANASETTI C BENSINGER WI CLIFT RA HANSEN JA SANDERS JE STORB R APPELBAUM FR
Citation: Je. Anderson et al., STEM-CELL TRANSPLANTATION FOR SECONDARY ACUTE MYELOID-LEUKEMIA - EVALUATION OF TRANSPLANTATION AS INITIAL THERAPY OR FOLLOWING INDUCTION CHEMOTHERAPY, Blood, 89(7), 1997, pp. 2578-2585
AN ANTIBODY TO CD44 ENHANCES HEMATOPOIESIS IN LONG-TERM MARROW CULTURES
Authors: ROSSBACH HC KRIZANACBENGEZ L SANTOS EB GOOLEY TA SANDMAIER BM
Citation: Hc. Rossbach et al., AN ANTIBODY TO CD44 ENHANCES HEMATOPOIESIS IN LONG-TERM MARROW CULTURES, Experimental hematology, 24(2), 1996, pp. 221-227
HIGH-DOSE FRACTIONATED TOTAL-BODY IRRADIATION, ETOPOSIDE AND CYCLOPHOSPHAMIDE FOR TREATMENT OF MALIGNANT-LYMPHOMA - COMPARISON OF AUTOLOGOUS BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELLS
Authors: BRUNVAND MW BENSINGER WI SOLL E WEAVER CH ROWLEY SD APPELBAUM FR LILLEBY K CLIFT RA GOOLEY TA PRESS OW FEFER A STORB R SANDERS JE MARTIN PL CHAUNCEY T MAZIARZ RT ZUCKERMAN N MONTGOMERY P DORN R WEIDEN PL DEMIRER T HOLMBERG LA SCHIFFMAN K MCSWEENEY PA MALONEY DG BUCKNER CD
Citation: Mw. Brunvand et al., HIGH-DOSE FRACTIONATED TOTAL-BODY IRRADIATION, ETOPOSIDE AND CYCLOPHOSPHAMIDE FOR TREATMENT OF MALIGNANT-LYMPHOMA - COMPARISON OF AUTOLOGOUS BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELLS, Bone marrow transplantation, 18(1), 1996, pp. 131-141
UNRELATED DONOR MARROW TRANSPLANTATION FOR MYELODYSPLASIA (MDS) AND MDS-RELATED ACUTE MYELOID-LEUKEMIA
Authors: ANDERSON JE ANASETTI C APPELBAUM FR SCHOCH G GOOLEY TA HANSEN JA BUCKNER CD SANDERS JE SULLIVAN KM STORB R
Citation: Je. Anderson et al., UNRELATED DONOR MARROW TRANSPLANTATION FOR MYELODYSPLASIA (MDS) AND MDS-RELATED ACUTE MYELOID-LEUKEMIA, British Journal of Haematology, 93(1), 1996, pp. 59-67
CYTOMEGALOVIRUS PP65 ANTIGENEMIA-GUIDED EARLY TREATMENT WITH GANCICLOVIR VERSUS GANCICLOVIR AT ENGRAFTMENT AFTER ALLOGENEIC MARROW TRANSPLANTATION - A RANDOMIZED DOUBLE-BLIND-STUDY
Authors: BOECKH M GOOLEY TA MYERSON D CUNNINGHAM T SCHOCH G BOWDEN RA
Citation: M. Boeckh et al., CYTOMEGALOVIRUS PP65 ANTIGENEMIA-GUIDED EARLY TREATMENT WITH GANCICLOVIR VERSUS GANCICLOVIR AT ENGRAFTMENT AFTER ALLOGENEIC MARROW TRANSPLANTATION - A RANDOMIZED DOUBLE-BLIND-STUDY, Blood, 88(10), 1996, pp. 4063-4071
ORAL BECLOMETHASONE DIPROPIONATE FOR TREATMENT OF HUMAN INTESTINAL GRAFT-VERSUS-HOST DISEASE
Authors: BAEHR PH LEVINE DS BOUVIER ME HOCKENBERY DM GOOLEY TA STERN JG MARTIN PJ MCDONALD GB
Citation: Ph. Baehr et al., ORAL BECLOMETHASONE DIPROPIONATE FOR TREATMENT OF HUMAN INTESTINAL GRAFT-VERSUS-HOST DISEASE, Transplantation, 60(11), 1995, pp. 1231-1238
FAILURE OF HIGH-DOSE ACYCLOVIR TO PREVENT CYTOMEGALOVIRUS DISEASE AFTER AUTOLOGOUS MARROW TRANSPLANTATION
Authors: BOECKH M GOOLEY TA REUSSER P BUCKNER CD BOWDEN RA
Citation: M. Boeckh et al., FAILURE OF HIGH-DOSE ACYCLOVIR TO PREVENT CYTOMEGALOVIRUS DISEASE AFTER AUTOLOGOUS MARROW TRANSPLANTATION, The Journal of infectious diseases, 172(4), 1995, pp. 939-943
QUANTITATIVE CD34 COLLECTION DOES NOT INDEPENDENTLY PREDICT CLINICAL OUTCOME AFTER AUTOLOGOUS PBSC TRANSPLANTATION (APBSCT)
Authors: CHAUNCEY TR GOOLEY TA APPELBAUM FR DEMIRER T HOLMBERG L LILLEBY K ROWLEY SD BUCKNER CD
Citation: Tr. Chauncey et al., QUANTITATIVE CD34 COLLECTION DOES NOT INDEPENDENTLY PREDICT CLINICAL OUTCOME AFTER AUTOLOGOUS PBSC TRANSPLANTATION (APBSCT), Blood, 86(10), 1995, pp. 3751-3751
SIMULATION AS A DESIGN TOOL FOR PHASE I II CLINICAL-TRIALS - AN EXAMPLE FROM BONE-MARROW TRANSPLANTATION/
Authors: GOOLEY TA MARTIN PJ FISHER LD PETTINGER M
Citation: Ta. Gooley et al., SIMULATION AS A DESIGN TOOL FOR PHASE I II CLINICAL-TRIALS - AN EXAMPLE FROM BONE-MARROW TRANSPLANTATION/, Controlled clinical trials, 15(6), 1994, pp. 450-462
PREDICTION OF CYTOMEGALOVIRUS PNEUMONIA AFTER MARROW TRANSPLANTATION FROM CELLULAR CHARACTERISTICS AND CYTOMEGALOVIRUS CULTURE OF BRONCHOALVEOLAR, LAVAGE FLUID
Authors: SLAVIN MA GOOLEY TA BOWDEN RA
Citation: Ma. Slavin et al., PREDICTION OF CYTOMEGALOVIRUS PNEUMONIA AFTER MARROW TRANSPLANTATION FROM CELLULAR CHARACTERISTICS AND CYTOMEGALOVIRUS CULTURE OF BRONCHOALVEOLAR, LAVAGE FLUID, Transplantation, 58(8), 1994, pp. 915-919
PREDICTION OF CYTOMEGALOVIRUS PNEUMONIA AFTER MARROW TRANSPLANTATION FROM CELLULAR CHARACTERISTICS AND CYTOMEGALOVIRUS CULTURE OF BRONCHOALVEOLAR, LAVAGE FLUID
Authors: SLAVIN MA GOOLEY TA BOWDEN RA
Citation: Ma. Slavin et al., PREDICTION OF CYTOMEGALOVIRUS PNEUMONIA AFTER MARROW TRANSPLANTATION FROM CELLULAR CHARACTERISTICS AND CYTOMEGALOVIRUS CULTURE OF BRONCHOALVEOLAR, LAVAGE FLUID, Transplantation, 58(8), 1994, pp. 915-919
EFFECT OF CELL CONCENTRATION ON BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELL CRYOPRESERVATION
Authors: ROWLEY SD BENSINGER WI GOOLEY TA BUCKNER CD
Citation: Sd. Rowley et al., EFFECT OF CELL CONCENTRATION ON BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELL CRYOPRESERVATION, Blood, 83(9), 1994, pp. 2731-2736
Risultati: 1-17 |